SRTS
Sensus Healthcare, Inc.
Price Chart
Latest Quote
$2.79
+0.06 (+2.20%)
Current Price
| Previous Close | $2.73 |
| Open | $2.68 |
| Day High | $2.79 |
| Day Low | $2.68 |
| Volume | 48,105 |
Stock Information
| Shares Outstanding | 16.46M |
| Total Debt | $407K |
| Cash Equivalents | $18.33M |
| Revenue | $22.53M |
| Net Income | $-7.77M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $45.93M |
| EPS (TTM) | $-0.47 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $26.69M |
| Sales | $22.53M |
| Income | $-7.77M |
| Book/sh | $2.92 |
| Cash/sh | $1.11 |
| Employees | 60 |
Financial Ratios
| Quick Ratio | 3.74 |
| Current Ratio | 7.27 |
| Debt/Eq | 0.89 |
Returns & Margins
| ROA | -13.44% |
| ROE | -15.77% |
| Gross Margin | 37.74% |
| Operating Margin | -128.40% |
| Profit Margin | -34.50% |
Ownership
| Insider Ownership | 17.86% |
| Institutional Ownership | 29.09% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -167.37 |
| P/S | 2.04 |
| P/B | 0.96 |
Analyst Data
| Recommendation | none |
| Target Price | $5.75 |
Technical Indicators
| SMA20 | $2.88 |
| SMA50 | $3.51 |
| SMA200 | $3.84 |
| RSI | 29.17 |
| ATR | 0.1575 |
| Shares Float | 13.55M |
| Short Float | 1.35% |
| Short Ratio | 2.30 |
| Volatility | 1.09 |
| Rel Volume | 0.81 |
Performance History
| Week | +2.95% |
| Month | -16.72% |
| Quarter | -29.90% |
| 6 Months | -26.58% |
| YTD | -31.95% |
| Year | -42.12% |
| 3 Years | -10.00% |
| 5 Years | -37.30% |
| 10 Years | -52.31% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $2.79 | 51,000 |
| 2026-06-17 | $2.73 | 27,000 |
| 2026-06-16 | $2.71 | 56,400 |
| 2026-06-15 | $2.71 | 24,400 |
| 2026-06-12 | $2.71 | 32,000 |
| 2026-06-11 | $2.71 | 15,800 |
| 2026-06-10 | $2.82 | 50,400 |
| 2026-06-09 | $2.70 | 40,700 |
| 2026-06-08 | $2.69 | 46,400 |
| 2026-06-05 | $2.70 | 53,300 |
| 2026-06-04 | $2.82 | 46,000 |
| 2026-06-03 | $2.84 | 30,900 |
| 2026-06-02 | $2.84 | 80,200 |
| 2026-06-01 | $2.85 | 353,400 |
| 2026-05-29 | $3.09 | 66,900 |
| 2026-05-28 | $3.18 | 52,400 |
| 2026-05-27 | $3.13 | 110,600 |
| 2026-05-26 | $3.20 | 34,400 |
| 2026-05-22 | $3.19 | 38,000 |
| 2026-05-21 | $3.23 | 44,200 |
| 2026-05-20 | $3.32 | 32,900 |
| 2026-05-19 | $3.35 | 23,400 |
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.
đ° Latest News
How The Sensus Healthcare (SRTS) Story Is Shifting With New Targets And 2026 Reimbursement Changes
Simply Wall St. âĸ 2026-05-20T14:13:39Z
Sensus Healthcare Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-09T02:05:47Z
Sensus (SRTS) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-07T22:50:52Z
Pleasing Signs As A Number Of Insiders Buy Sensus Healthcare Stock
Simply Wall St. âĸ 2026-05-06T11:58:23Z
2 Reasons Why Wells Fargo Thinks You Should Buy Google Stock Now
Barchart âĸ 2026-03-31T11:30:02Z
Why The Sensus Healthcare (SRTS) Story Is Shifting As Targets Diverge On 2026 Expectations
Simply Wall St. âĸ 2026-03-11T16:12:30Z
Sensus Healthcare, Inc. (NASDAQ:SRTS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Simply Wall St. âĸ 2026-02-15T12:04:36Z
Sensus Healthcare, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-02-13T13:30:00Z
Sensus Healthcare Inc (SRTS) Q4 2025 Earnings Call Highlights: Navigating Challenges with ...
GuruFocus.com âĸ 2026-02-13T05:03:44ZSensus Healthcare Q4 Earnings Call Highlights
MarketBeat âĸ 2026-02-13T02:07:27Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $15,615,000 | $17,376,000 | $10,345,000 | $14,904,000 |
| Cost Of Revenue | $15,615,000 | $17,376,000 | $10,345,000 | $14,904,000 |
| Total Revenue | $27,482,000 | $41,807,000 | $24,405,000 | $44,532,000 |
| Operating Revenue | $27,482,000 | $41,807,000 | $24,405,000 | $44,532,000 |
| Expenses | ||||
| Total Expenses | $37,789,000 | $33,717,000 | $24,787,000 | $29,701,000 |
| Net Non Operating Interest Income Expense | $683,000 | $932,000 | $992,000 | $380,000 |
| Operating Expense | $22,174,000 | $16,341,000 | $14,442,000 | $14,797,000 |
| Selling And Marketing Expense | $6,523,000 | $4,978,000 | $5,608,000 | $6,329,000 |
| General And Administrative Expense | $7,873,000 | $7,147,000 | $5,156,000 | $5,008,000 |
| Other Income Expense | - | - | $42,000 | $12,779,000 |
| Interest Expense | - | - | - | $2,000 |
| Interest Expense Non Operating | - | - | - | $2,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-7,719,000 | $6,647,000 | $485,000 | $24,244,000 |
| Net Interest Income | $683,000 | $932,000 | $992,000 | $380,000 |
| Interest Income | $683,000 | $932,000 | $992,000 | $380,000 |
| Normalized Income | $-7,719,000 | $6,647,000 | $453,752 | $13,177,386 |
| Net Income From Continuing And Discontinued Operation | $-7,719,000 | $6,647,000 | $485,000 | $24,244,000 |
| Total Operating Income As Reported | $-10,307,000 | $8,090,000 | $-382,000 | $14,831,000 |
| Net Income Common Stockholders | $-7,719,000 | $6,647,000 | $485,000 | $24,244,000 |
| Net Income | $-7,719,000 | $6,647,000 | $485,000 | $24,244,000 |
| Net Income Including Noncontrolling Interests | $-7,719,000 | $6,647,000 | $485,000 | $24,244,000 |
| Net Income Continuous Operations | $-7,719,000 | $6,647,000 | $485,000 | $24,244,000 |
| Pretax Income | $-9,624,000 | $9,022,000 | $652,000 | $27,990,000 |
| Interest Income Non Operating | $683,000 | $932,000 | $992,000 | $380,000 |
| Operating Income | $-10,307,000 | $8,090,000 | $-382,000 | $14,831,000 |
| Gross Profit | $11,867,000 | $24,431,000 | $14,060,000 | $29,628,000 |
| Special Income Charges | - | $0 | $42,000 | $12,779,000 |
| Per Share | ||||
| Diluted EPS | $-0.47 | $0.41 | $0.03 | $1.46 |
| Basic EPS | $-0.47 | $0.41 | $0.03 | $1.47 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $10,752 | $1,712,386 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-9,681,000 | $8,522,000 | $37,000 | $2,561,000 |
| Reconciled Depreciation | $626,000 | $432,000 | $461,000 | $509,000 |
| EBITDA (Bullshit earnings) | $-9,681,000 | $8,522,000 | $79,000 | $15,340,000 |
| EBIT | $-10,307,000 | $8,090,000 | $-382,000 | $14,831,000 |
| Diluted Average Shares | $16,326,937 | $16,359,616 | $16,266,139 | $16,618,214 |
| Basic Average Shares | $16,326,937 | $16,312,351 | $16,259,254 | $16,480,991 |
| Diluted NI Availto Com Stockholders | $-7,719,000 | $6,647,000 | $485,000 | $24,244,000 |
| Tax Provision | $-1,905,000 | $2,375,000 | $167,000 | $3,746,000 |
| Research And Development | $7,778,000 | $4,216,000 | $3,678,000 | $3,460,000 |
| Selling General And Administration | $14,396,000 | $12,125,000 | $10,764,000 | $11,337,000 |
| Other Gand A | $7,873,000 | $7,147,000 | $5,156,000 | $5,008,000 |
| Total Unusual Items | - | $0 | $42,000 | $12,779,000 |
| Total Unusual Items Excluding Goodwill | - | $0 | $42,000 | $12,779,000 |
| Gain On Sale Of Ppe | - | $0 | $42,000 | $12,779,000 |
| Restructuring And Mergern Acquisition | - | - | - | - |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $48,098,000 | $55,827,000 | $48,842,000 | $48,069,000 |
| Total Assets | $53,039,000 | $62,165,000 | $53,710,000 | $56,735,000 |
| Total Non Current Assets | $7,147,000 | $5,427,000 | $4,182,000 | $3,494,000 |
| Other Non Current Assets | $640,000 | $652,000 | $804,000 | $542,000 |
| Non Current Deferred Assets | $4,079,000 | $2,197,000 | $2,140,000 | $1,713,000 |
| Non Current Deferred Taxes Assets | $4,079,000 | $2,197,000 | $2,140,000 | $1,713,000 |
| Current Assets | $45,892,000 | $56,738,000 | $49,528,000 | $53,241,000 |
| Other Current Assets | $1,683,000 | $1,507,000 | $888,000 | $660,000 |
| Prepaid Assets | $1,522,000 | $3,347,000 | $2,986,000 | $6,261,000 |
| Inventory | $14,563,000 | $10,097,000 | $11,861,000 | $3,501,000 |
| Receivables | $6,041,000 | $19,731,000 | $10,645,000 | $17,299,000 |
| Accounts Receivable | $6,041,000 | $19,731,000 | $10,645,000 | $17,299,000 |
| Allowance For Doubtful Accounts Receivable | $-100,000 | $-100,000 | $0 | $-107,000 |
| Gross Accounts Receivable | $6,141,000 | $19,831,000 | $10,645,000 | $17,406,000 |
| Cash Cash Equivalents And Short Term Investments | $22,083,000 | $22,056,000 | $23,148,000 | $25,520,000 |
| Cash And Cash Equivalents | $22,083,000 | $22,056,000 | $23,148,000 | $25,520,000 |
| Non Current Prepaid Assets | - | - | - | $24,000 |
| Goodwill And Other Intangible Assets | - | - | - | $50,000 |
| Other Intangible Assets | - | - | - | $50,000 |
| Debt | ||||
| Total Debt | $471,000 | $602,000 | $783,000 | $1,020,000 |
| Long Term Debt And Capital Lease Obligation | $209,000 | $398,000 | $596,000 | $830,000 |
| Current Debt And Capital Lease Obligation | $262,000 | $204,000 | $187,000 | $190,000 |
| Current Debt | - | - | - | - |
| Other Current Borrowings | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $4,941,000 | $6,338,000 | $4,868,000 | $8,666,000 |
| Total Non Current Liabilities Net Minority Interest | $219,000 | $453,000 | $656,000 | $969,000 |
| Non Current Deferred Liabilities | $10,000 | $55,000 | $60,000 | $139,000 |
| Current Liabilities | $4,722,000 | $5,885,000 | $4,212,000 | $7,697,000 |
| Current Deferred Liabilities | $842,000 | $541,000 | $657,000 | $693,000 |
| Payables And Accrued Expenses | $3,343,000 | $4,811,000 | $2,830,000 | $6,411,000 |
| Payables | $3,343,000 | $4,811,000 | $2,830,000 | $6,411,000 |
| Accounts Payable | $3,343,000 | $4,811,000 | $2,793,000 | $5,521,000 |
| Total Tax Payable | - | $0 | $37,000 | $890,000 |
| Income Tax Payable | - | $0 | $37,000 | $890,000 |
| Other Current Liabilities | - | - | - | $403,000 |
| Equity | ||||
| Common Stock Equity | $48,098,000 | $55,827,000 | $48,842,000 | $48,069,000 |
| Total Equity Gross Minority Interest | $48,098,000 | $55,827,000 | $48,842,000 | $48,069,000 |
| Stockholders Equity | $48,098,000 | $55,827,000 | $48,842,000 | $48,069,000 |
| Retained Earnings | $5,715,000 | $13,434,000 | $6,787,000 | $6,302,000 |
| Other | ||||
| Treasury Shares Number | $593,036 | $541,449 | $532,924 | $512,342 |
| Ordinary Shares Number | $16,463,809 | $16,495,396 | $16,374,171 | $16,390,419 |
| Share Issued | $17,056,845 | $17,036,845 | $16,907,095 | $16,902,761 |
| Tangible Book Value | $48,098,000 | $55,827,000 | $48,842,000 | $48,069,000 |
| Invested Capital | $48,098,000 | $55,827,000 | $48,842,000 | $48,069,000 |
| Working Capital | $41,170,000 | $50,853,000 | $45,316,000 | $45,544,000 |
| Capital Lease Obligations | $471,000 | $602,000 | $783,000 | $1,020,000 |
| Total Capitalization | $48,098,000 | $55,827,000 | $48,842,000 | $48,069,000 |
| Treasury Stock | $3,876,000 | $3,571,000 | $3,519,000 | $3,433,000 |
| Additional Paid In Capital | $46,090,000 | $45,795,000 | $45,405,000 | $45,031,000 |
| Capital Stock | $169,000 | $169,000 | $169,000 | $169,000 |
| Common Stock | $169,000 | $169,000 | $169,000 | $169,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $10,000 | $55,000 | $60,000 | $139,000 |
| Long Term Capital Lease Obligation | $209,000 | $398,000 | $596,000 | $830,000 |
| Current Deferred Revenue | $842,000 | $541,000 | $657,000 | $693,000 |
| Current Capital Lease Obligation | $262,000 | $204,000 | $187,000 | $190,000 |
| Current Provisions | $275,000 | $329,000 | $538,000 | $403,000 |
| Net PPE | $2,428,000 | $2,578,000 | $1,238,000 | $1,239,000 |
| Accumulated Depreciation | $-2,442,000 | $-2,120,000 | $-1,883,000 | $-2,131,000 |
| Gross PPE | $4,870,000 | $4,698,000 | $3,121,000 | $3,370,000 |
| Construction In Progress | $474,000 | $228,000 | $0 | - |
| Other Properties | $4,210,000 | $4,302,000 | $2,976,000 | $3,208,000 |
| Machinery Furniture Equipment | $186,000 | $168,000 | $145,000 | $162,000 |
| Finished Goods | - | - | - | $3,501,000 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $332,000 | $-1,107,000 | $-2,374,000 | $-1,571,000 |
| Operating Activities | ||||
| Operating Cash Flow | $528,000 | $-831,000 | $-2,145,000 | $-1,412,000 |
| Cash Flow From Continuing Operating Activities | $528,000 | $-831,000 | $-2,145,000 | $-1,412,000 |
| Operating Gains Losses | - | - | $-42,000 | $-12,582,000 |
| Investing Activities | ||||
| Capital Expenditure | $-196,000 | $-276,000 | $-229,000 | $-159,000 |
| Investing Cash Flow | $-196,000 | $-276,000 | $-187,000 | $14,841,000 |
| Cash Flow From Continuing Investing Activities | $-196,000 | $-276,000 | $-187,000 | $14,841,000 |
| Net Other Investing Changes | - | - | $42,000 | $15,000,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-300,000 | $0 | $-27,000 | $-2,999,000 |
| Financing Cash Flow | $-305,000 | $15,000 | $-40,000 | $-2,428,000 |
| Cash Flow From Continuing Financing Activities | $-305,000 | $15,000 | $-40,000 | $-2,428,000 |
| Net Other Financing Charges | $-5,000 | $-52,000 | $-59,000 | $-109,000 |
| Net Common Stock Issuance | $-300,000 | $0 | $-27,000 | $-2,999,000 |
| Other | ||||
| Interest Paid Supplemental Data | $0 | $0 | $0 | $2,000 |
| Income Tax Paid Supplemental Data | $980,000 | $2,582,000 | $1,440,000 | $4,570,000 |
| End Cash Position | $22,083,000 | $22,056,000 | $23,148,000 | $25,520,000 |
| Beginning Cash Position | $22,056,000 | $23,148,000 | $25,520,000 | $14,519,000 |
| Changes In Cash | $27,000 | $-1,092,000 | $-2,372,000 | $11,001,000 |
| Proceeds From Stock Option Exercised | $0 | $67,000 | $46,000 | $731,000 |
| Common Stock Payments | $-300,000 | $0 | $-27,000 | $-2,999,000 |
| Net PPE Purchase And Sale | $-196,000 | $-276,000 | $-229,000 | $-159,000 |
| Purchase Of PPE | $-196,000 | $-276,000 | $-229,000 | $-159,000 |
| Change In Working Capital | $8,661,000 | $-8,554,000 | $-3,560,000 | $-12,924,000 |
| Change In Other Working Capital | $-301,000 | $-585,000 | $-583,000 | $-1,429,000 |
| Change In Other Current Liabilities | $-242,000 | $-181,000 | $-201,000 | $-199,000 |
| Change In Other Current Assets | $-164,000 | $-467,000 | $-540,000 | $294,000 |
| Change In Payables And Accrued Expense | $-1,468,000 | $1,981,000 | $-3,581,000 | $1,689,000 |
| Change In Payable | $-1,468,000 | $1,981,000 | $-3,581,000 | $1,689,000 |
| Change In Account Payable | $-1,468,000 | $2,018,000 | $-2,728,000 | $799,000 |
| Change In Tax Payable | $0 | $-37,000 | $-853,000 | $890,000 |
| Change In Income Tax Payable | $0 | $-37,000 | $-853,000 | $890,000 |
| Change In Prepaid Assets | $1,825,000 | $-361,000 | $3,275,000 | $-4,774,000 |
| Change In Inventory | $-4,635,000 | $268,000 | $-8,577,000 | $-3,191,000 |
| Change In Receivables | $13,646,000 | $-9,209,000 | $6,647,000 | $-5,314,000 |
| Changes In Account Receivables | $13,646,000 | $-9,209,000 | $6,647,000 | $-5,314,000 |
| Stock Based Compensation | $295,000 | $323,000 | $328,000 | $187,000 |
| Provisionand Write Offof Assets | $547,000 | $378,000 | $603,000 | $722,000 |
| Deferred Tax | $-1,882,000 | $-57,000 | $-427,000 | $-1,713,000 |
| Deferred Income Tax | $-1,882,000 | $-57,000 | $-427,000 | $-1,713,000 |
| Depreciation Amortization Depletion | $626,000 | $432,000 | $461,000 | $509,000 |
| Depreciation And Amortization | $626,000 | $432,000 | $461,000 | $509,000 |
| Depreciation | $626,000 | $432,000 | $461,000 | $509,000 |
| Net Income From Continuing Operations | $-7,719,000 | $6,647,000 | $485,000 | $24,244,000 |
| Asset Impairment Charge | - | $123,000 | $7,000 | $145,000 |
| Repayment Of Debt | - | - | $0 | $-51,000 |
| Net Issuance Payments Of Debt | - | - | $0 | $-51,000 |
| Net Long Term Debt Issuance | - | - | $0 | $-51,000 |
| Long Term Debt Payments | - | - | $0 | $-51,000 |
| Net Short Term Debt Issuance | - | - | - | $-51,000 |
| Short Term Debt Payments | - | - | - | $-51,000 |
| Amortization Cash Flow | - | - | - | $96,000 |
| Amortization Of Intangibles | - | - | - | $96,000 |
| Gain Loss On Sale Of PPE | - | - | - | $0 |
| Issuance Of Debt | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
| Net Investment Purchase And Sale | - | - | - | - |
| Sale Of Investment | - | - | - | - |
| Sale Of PPE | - | - | - | - |
| Other Non Cash Items | - | - | - | - |
Fetched: 2026-06-18